Antimicrobial Agents and Chemotherapy

Antimicrobial Agents and Chemotherapy (print-ISSN 0066-4804, CODEN AMACCQ; canceled ISSN 0074-9923, canceled CODEN AACHAX) is an academic journal published by the American Society for Microbiology. Antimicrobial Agents and Chemotherapy is a major forum devoted exclusively to antimicrobial, antiviral, antifungal, and antiparasitic agents and chemotherapy. It is a key resource for microbiologists, researchers, biochemists, pharmacologists, clinicians, and other specialist in infectious diseases.

Some content from Wikipedia, licensed under CC BY-SA

Diseases, Conditions, Syndromes

Researchers' discovery may explain difficulty in treating Lyme disease

Northeastern University researchers have found that the bacterium that causes Lyme disease forms dormant persister cells, which are known to evade antibiotics. This significant finding, they said, could help explain why it's ...

Medications

Likely drug interactions in placenta could harm fetus

To date, studies in pregnant women examining transport of drugs across the placenta are rare and inadequate, said Tomo Nabekura, PhD. Such knowledge could be vital to preserving fetal health. In a new laboratory study, Nabekura ...

Diseases, Conditions, Syndromes

Scientists set sights on glaucoma medication to treat TB

A new discovery by Michigan State University scientists suggests that a common medication used to treat glaucoma could also be used to treat tuberculosis, even the drug-resistant kind.

Diseases, Conditions, Syndromes

Hospital disinfectants struggling to kill C. diff bacteria colonies

The deadly and notoriously stubborn superbug, Clostridioides difficile (C. diff), is putting up a winning fight against hospital-grade disinfectants meant to kill it, according to results of a new study published in the Antimicrobial ...

HIV & AIDS

Stopping HIV in its tracks

Is the end of HIV near? Findings published this week in Antimicrobial Agents and Chemotherapy report that a novel, subdermal implant delivering potent antiretroviral (ARV) drugs shows extreme promise in stopping the spread ...

Diseases, Conditions, Syndromes

Resistance to last resort drug arose in patient over 3 weeks

French investigators have described development of resistance to one of the last resort therapies used to treat extremely drug-resistant Pseudomonas aeruginosa. That resistance arose in a single patient over a scant 22 days. ...

page 1 from 13